Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Study of the Pharmacokinetics and Safety Including HPA Axis Suppression Potential of Clobetasol Topical Oil in Pediatric Subjects With Moderate to Severe Atopic Dermatitis

NCT03847389 is registered in ClinicalTrials.gov with Hill Dermaceuticals, Inc. as lead sponsor.

NCT NCT03847389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03847389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Study of the Pharmacokinetics and Safety Including HPA Axis Suppression Potential of Clobetasol Topical Oil in Pediatric Subjects With Moderate to Severe Atopic Dermatitis
Lead sponsor
Hill Dermaceuticals, Inc.
Phase
Phase 1/2
Overall status
Terminated
Start date
September 9, 2019
Completion date
July 28, 2020
Enrollment
8 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis